Munier AL - Search Results

1

Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort study.

Gazaignes S, Resche-Rigon M, Yang C, Gatey C, Munier AL, Desseaux K, Rozenbaum W, Molina JM. Gazaignes S, et al. Among authors: munier al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19796. doi: 10.7448/IAS.17.4.19796. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397540 Free PMC article.

2

Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.

Munier AL, de Lastours V, Porcher R, Donay JL, Pons JL, Molina JM. Munier AL, et al. Int J STD AIDS. 2014 Dec;25(14):1022-8. doi: 10.1177/0956462414528316. Epub 2014 Mar 27. Int J STD AIDS. 2014. PMID: 24676129

3

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.

Ghislain M, Bastard JP, Meyer L, Capeau J, Fellahi S, Gérard L, May T, Simon A, Vigouroux C, Goujard C; ANRS-COPANA Cohort Study Group. Ghislain M, et al. PLoS One. 2015 Dec 4;10(12):e0144317. doi: 10.1371/journal.pone.0144317. eCollection 2015. PLoS One. 2015. PMID: 26636578 Free PMC article. Clinical Trial.

4

Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.

Munier AL, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay JL, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM. Munier AL, et al. Int J Infect Dis. 2019 Feb;79:179-184. doi: 10.1016/j.ijid.2018.11.371. Epub 2018 Dec 6. Int J Infect Dis. 2019. PMID: 30529108 Free article.

5

A highly virulent variant of HIV-1 circulating in the Netherlands.

Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.

6

New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction-Confirmed Cases.

Dulin M, Chevret S, Salmona M, Jacquier H, Bercot B, Molina JM, Lebeaux D, Munier AL. Dulin M, et al. Among authors: munier al. Open Forum Infect Dis. 2024 Jun 20;11(7):ofae340. doi: 10.1093/ofid/ofae340. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38957692 Free PMC article. Clinical Trial.

7

Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.

Sellier PO, Maylin S, Brichler S, Berçot B, Lopes A, Chopin D, Pogliaghi M, Munier AL, Delcey V, Simoneau G, Evans J, Gordien E, Simon F, Bergmann JF. Sellier PO, et al. Among authors: munier al. Liver Int. 2018 Apr;38(4):611-618. doi: 10.1111/liv.13556. Epub 2017 Sep 12. Liver Int. 2018. PMID: 28834623

8

Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study.

Jacquier H, Fihman V, Amarsy R, Vicaut E, Bousson V, Cambau E, Crémieux AC, Delcey V, Hannouche D, Kaci R, Laredo JD, Meunier F, Nizard R, Ottaviani S, Parlier C, Richette P, Sellier P, Zadegan F, Lioté F, Berçot B; Molos Study Group. Jacquier H, et al. Open Forum Infect Dis. 2019 Dec 2;6(12):ofz511. doi: 10.1093/ofid/ofz511. eCollection 2019 Dec. Open Forum Infect Dis. 2019. PMID: 31909081 Free PMC article.

9

Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment.

Munier AL, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R. Munier AL, et al. Int J Antimicrob Agents. 2015 Dec;46(6):653-9. doi: 10.1016/j.ijantimicag.2015.09.004. Epub 2015 Oct 9. Int J Antimicrob Agents. 2015. PMID: 26508586 Clinical Trial.

10

O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance.

Royer G, Clermont O, Condamine B, Mercier-Darty M, Laouénan C, Lefort A, Denamur E, de Lastours V; COLIBAFI and SEPTICOLI Groups. Royer G, et al. Clin Infect Dis. 2022 Jan 29;74(2):364-366. doi: 10.1093/cid/ciab458. Clin Infect Dis. 2022. PMID: 34000003 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters